17 alpha-hydroxylase deficiency: Difference between revisions
No edit summary |
No edit summary |
||
Line 9: | Line 9: | ||
==[[Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency historical perspective|Historical Perspective]]== | ==[[Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency historical perspective|Historical Perspective]]== | ||
==[[Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency pathophysiology|Pathophysiology]]== | ==[[Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency pathophysiology|Pathophysiology]]== |
Revision as of 21:26, 2 February 2016
Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
17 alpha-hydroxylase deficiency On the Web |
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency |
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Synonyms and keywords: 17 alpha-hydroxylase deficiency; 17 alpha-hydroxylase deficiency; Adrenal hyperplasia, hypertensive form; Deficiency of steroid 17 alpha-monooxygenase; Steroid 17 alpha hydroxylase deficiency
For patient information, click here.
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency From Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies